Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.54
$0.35 (+10.97%)
$3.26Day Range$3.59
Key Statistics
Market Cap
$1.90B
Shares Outstanding
536.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 16, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$3.28
Day High
$3.59
Day Low
$3.26
Volume
28.25M
VWAP
$3.49
Prev Close
$3.19
Transactions
--
Acc. Volume
--
About Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836600 employees41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101(385) 269-0203IPO Apr 16, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001601830
- Composite FIGI
- BBG00PQ4XJ45
- Share Class FIGI
- BBG00PQ4XJ54
- Ticker Root
- RXRX
- SIC Code
- 2836
About Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Stock
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) closed the 2026-09-17 session at $3.54, up 10.97% versus the previous close (+0.35). The stock opened at $3.28 and traded between $3.26 and $3.59 during that session. Session trading volume was 28.3M shares. The volume-weighted average price (VWAP) is $3.49.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Recursion Pharmaceuticals, Inc. Class A Common Stock has a market capitalization of $1.90 billion. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. RXRX is listed on the XNAS exchange. The company employs approximately 600 people. Recursion Pharmaceuticals, Inc. Class A Common Stock is headquartered in SALT LAKE CITY, UT. The recorded listing date is 2021-04-16.
On this page you can find market RXRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.